Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Russian mRNA cancer 'vaccine' shows promise in pre-clinical trials, part of growing immunotherapy trend in cancer treatment.

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

The study, published by the McCullough Foundation, says the deaths reported in VAERS are estimated to be underreported by a ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The company's financials are heavily reliant on COVID-19 vaccines, with declining demand impacting revenue and profitability. BioNTech's strong balance sheet and innovative mRNA technology show ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting large-scale clinical trials for potential vaccine candidates remains a ...

Investing.com -- Moderna (NASDAQ: NASDAQ: MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ: BNTX) shares fell 1.5% ...